Keywords:
cancer of unknown primary, adenocarcinoma, immunohistochemistry, bone metastases, pancreatobiliary tumor.References
National Clinical Guidelines. Malignant Neoplasms of Unknown Primary Site. Ministry of Health of the Russian Federation, 2023.
Fizazi K., et al. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2023; 34(3): 228-246.
Rassy E., et al. Advances in the management of cancer of unknown primary. Nat Rev Clin Oncol. 2022; 19(1): 41-52.
Hayashi H., et al. A systematic review of cancer of unknown primary: Is next-generation sequencing leading the way? Cancer Treat Rev. 2023; 115: 102527.
Kato S., et al. Utility of Genomic Analysis in Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary. Cancer Res. 2022; 82(1): 33-44.
Gatalica Z., et al. Comprehensive tumor profiling in 15,000 patients with carcinoma of unknown primary: The (CUP) pancancer experience. J Clin Oncol. 2021; 39(15_suppl): 3073.
Rimmer A., et al. Immunohistochemistry in the Diagnosis of Cancer of Unknown Primary: A Practical Guide. Arch Pathol Lab Med. 2022; 146(1): 30-39.
Conroy T., et al. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med. 2018; 379(25): 2395-2406.
Sweeny L., et al. Diagnostic Utility of S100P in Pancreatobiliary Adenocarcinoma: A Comparative Immunohistochemical Study. Am J Surg Pathol. 2021; 45(3): 371-378.
Coleman R., et al. Bone health in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2022; 33(Suppl 7): S1-S12.
Epstein J.I., et al. The 2022 International Society of Urological Pathology (ISUP) Consensus Conference on Grading and Staging of Prostatic Carcinoma. Am J Surg Pathol. 2023; 47(1): e1-e10.
Hüneburg R., et al. S100P is a strong diagnostic marker for pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm. Pancreatology. 2021; 21(1): 183-190.
Litvitsky P.F., et al. Clinical Oncology: Modern Aspects of Diagnosis and Treatment. Moscow: GEOTAR-Media, 2022.
Sung H., et al. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2024; 74(3): 229-263.
Chakrabarti S., et al. Metastatic carcinoma of unknown primary: A diagnostic and therapeutic dilemma. Cancer Treat Res Commun. 2023; 34: 100678.